{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:12:47Z","timestamp":1792033967184,"version":"4.4.0"},"reference-count":19,"publisher":"Scientific Scholar","issue":"04","license":[{"start":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T00:00:00Z","timestamp":1582070400000},"content-version":"vor","delay-in-days":871,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Lab Physicians"],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          INTRODUCTION: Invasive pulmonary aspergillosis (IPA) is a major cause of morbidity and mortality in patients with hematological malignancies. In recent years, testing for values of galactomannan (GM) in serum and bronchoalveolar lavage (BAL) fluid has been investigated as a diagnostic test for IPA for such patients, but global experience and consensus on optical density (OD) cutoffs, especially for BAL galactomannan remains lacking.<\/jats:p><jats:p>\n          METHODS: We performed a prospective case\u2013control study to determine an optimal BAL GM OD cutoff for IPA in at-risk patients. Cases were subjects with hematological diagnoses who met established revised definitions for proven or probable IPA established by the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group (EORTC\/MSG, 2008), without the use of BAL GM results. Exclusion criteria included the use of piperacillin\/tazobactam and use of antifungals that were active against Aspergillus spp. before bronchoscopy. There were two control groups: patients with hematological diagnoses not meeting definitions for proven or probable IPA and patients with nonhematological diagnoses with no evidence of aspergillosis. Following bronchoscopy and BAL, GM testing was performed using the Platelia Aspergillus seroassay in accordance with the manufacturer\u2019s instructions.<\/jats:p><jats:p>\n          RESULTS: There were 51 cases and 20 controls. Cases had higher BAL fluid GM OD indices (ODIs) (mean: 1.27 and range: 0.4\u20133.78) compared with controls (mean: 0.26 and range: 0.09\u20130.35). Receiver operating characteristic analysis demonstrated an optimum ODI cutoff of 1.0, with high specificity (100%) and sensitivity (87.5%) for diagnosing IPA.<\/jats:p><jats:p>\n          CONCLUSIONS: Our results support BAL GM testing as a reasonably safe test with higher sensitivity compared to serum GM testing in at-risk patients with hematological diseases. A higher OD cutoff is necessary to avoid overdiagnosis of IPA.<\/jats:p>","DOI":"10.4103\/jlp.jlp_127_16","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T05:34:11Z","timestamp":1505108051000},"page":"234-238","source":"Crossref","is-referenced-by-count":18,"title":["Comparative evaluation of galactomannan test with bronchoalveolar lavage and serum for the diagnosis of invasive aspergillosis in patients with hematological malignancies"],"prefix":"10.25259","volume":"9","author":[{"given":"Ankit","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini R.","family":"Capoor","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trupti","family":"Shende","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritin","family":"Mohindra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Chander","family":"Suri","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipender Kumar","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Hematology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2020,2,19]]},"reference":[{"key":"key-10.4103\/0974-2727.214251-1","first-page":"447","volume-title":"Pathogenesis of Aspergillus fumigatus in invasive aspergillosis","author":"Dagenais","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0974-2727.214251-2","first-page":"1567","volume-title":"Invasive aspergillosis: Epidemiology, diagnosis and management in immunocompromised patients","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"key-10.4103\/0974-2727.214251-3","first-page":"S7","volume-title":"Clinical risk factors for invasive aspergillosis","author":"Baddley","year":"2011","journal-title":"Med Mycol"},{"key":"key-10.4103\/0974-2727.214251-4","first-page":"1524","volume-title":"Invasive aspergillosis in patients with acute leukemia: Update on morbidity and mortality \u2013 SEIFEM-C report","author":"Pagano","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-5","first-page":"1297","volume-title":"Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients","author":"Maertens","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-6","first-page":"1813","volume-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive fungal infections Cooperative Group and the National Institute of Allergy and infectious diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","author":"De","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-7","first-page":"505","volume-title":"Comparison of serum galactomannan and 1,3-beta-D-glucan determination for early detection of invasive pulmonary aspergillosis in critically ill patients with hematological malignancies and septic shock","author":"Lahmer","year":"2016","journal-title":"Mycopathologia"},{"key":"key-10.4103\/0974-2727.214251-8","first-page":"e0156566","volume-title":"Correction: Galactomannan testing and the incidence of invasive pulmonary aspergillosis: A 10-year nationwide population-based study in Taiwan","author":"Sun","year":"2016","journal-title":"PLoS One"},{"key":"key-10.4103\/0974-2727.214251-9","doi-asserted-by":"crossref","unstructured":"Imbert S, Gauthier L, Joly I, Brossas JY, Uzunov M, Touafek F, et al. Aspergillus PCR in serum for the diagnosis, follow-up and prognosis of invasive aspergillosis in neutropenic and nonneutropenic patients. Clin Microbiol Infect 2016;22:562.e1-8.","DOI":"10.1016\/j.cmi.2016.01.027"},{"key":"key-10.4103\/0974-2727.214251-10","first-page":"609","volume-title":"Laboratory diagnosis of invasive aspergillosis","author":"Hope","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-11","first-page":"1604","volume-title":"Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: A prospective validation","author":"Maertens","year":"2001","journal-title":"Blood"},{"key":"key-10.4103\/0974-2727.214251-12","first-page":"1417","volume-title":"Diagnosis of invasive aspergillosis using a galactomannan assay: A meta-analysis","author":"Pfeiffer","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-13","first-page":"2330","volume-title":"Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis","author":"Chai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-2727.214251-14","first-page":"448","volume-title":"Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis","author":"Becker","year":"2003","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0974-2727.214251-15","first-page":"817","volume-title":"Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: A bivariate metaanalysis and systematic review","author":"Guo","year":"2010","journal-title":"Chest"},{"key":"key-10.4103\/0974-2727.214251-16","first-page":"1688","volume-title":"Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases","author":"Maertens","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-17","first-page":"50","volume-title":"Galactomannan antigen detection using bronchial wash and bronchoalveolar lavage in patients with hematologic malignancies","author":"Taremi","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"key-10.4103\/0974-2727.214251-18","first-page":"44","volume-title":"Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients","author":"Hsu","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key-10.4103\/0974-2727.214251-19","first-page":"322","volume-title":"Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies","author":"Heng","year":"2014","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Laboratory Physicians"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/JLP.JLP_127_16.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,24]],"date-time":"2023-12-24T08:14:48Z","timestamp":1703405688000},"score":1,"resource":{"primary":{"URL":"https:\/\/jlabphy.org\/comparative-evaluation-of-galactomannan-test-with-bronchoalveolar-lavage-and-serum-for-the-diagnosis-of-invasive-aspergillosis-in-patients-with-hematological-malignancies\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":19,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2020,2,19]]},"published-print":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.4103\/jlp.jlp_127_16","relation":{},"ISSN":["0974-2727","0974-7826"],"issn-type":[{"value":"0974-2727","type":"print"},{"value":"0974-7826","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}